For buyers
Submit a structured RFQ
Describe your program brief and receive a fit-scored shortlist of CRO partners — ranked on capabilities, geography, and provenance-backed profile data, not paid placement.
Start RFQ briefSource the right CRO with fit-scored confidence
Independent research directory for biotech and pharma procurement — structured capabilities, provenance-backed profiles, and fit-aware shortlists.
Browse by capability
Jump into fit-scored shortlists for the outsourcing categories buyers evaluate most often.
- PreclinicalDiscovery through IND-enabling tox, PK, and in vivo models.
- Clinical Trials (Phases I–IV)Full-service clinical execution from first-in-human through post-market.
- OncologySolid tumor, hematologic, and immuno-oncology trial expertise.
- CNSNeurology and central nervous system program support.
- Decentralized Trials (DCT)Hybrid and decentralized clinical trial operations.
Live market intelligence
Daily headlines with sourcing, plus weekly macro analysis for outsourcing directors.
Daily operational updates
Source: PR Newswire pharma category RSS
Operational impact: [HkeyBio](/companies/hkeybio) Launches NHP FastPoC Program for LowCost Cynomolgus PK/PD Validation [HkeyBio](/companies/hkeybio) introduced NHP FastPoC, a streamlined preclinical service using small cynomolgus monkey co…
Source: PR Newswire pharma category RSS
Operational impact: SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver — Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281 VANCOUVER, BC, June 5…
Source: Endpoints News RSS
Operational impact: SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver — Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281 VANCOUVER, BC, June 5…
Source: PR Newswire pharma category RSS
Operational impact: SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver — Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281 VANCOUVER, BC, June 5…
Source: PR Newswire pharma category RSS
Operational impact: SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver — Clinical Study Showed Up to 48% Natural Killer Cell Increase with probiotic strain LP281 VANCOUVER, BC, June 5…
Weekly macro analysis
No weekly deep dive published yet. Deep dives run on a Tue/Thu UTC cadence per site when the content pipeline is enabled.
Get started
For vendors
Claim and optimize your profile
Verify your corporate email to add your logo and backlink, then complete domain verification for full profile admin, review responses, and buyer-facing visibility on cro.directory.
Claim your listing